To play content please upgrade your flash player to the latest version.
Professor Raphael Mechoulam, from The Hebrew University of Jerusalem, Israel will announce that the next stage will be human trials after the cannabidiol showed reduced memory loss on mice.
Cannabis has been humankind’s friend and foe for millennia and although a lot of recent press coverage has focused on the abuses associated with Cannabis, the plant has been an essential source of medicines over the years.
But it is very clear that Cannabis causes psychotic episodes and that there are real health risks involved. With the government currently looking at re-classifying the drug from a class C to a class B drug, is there any room for Cannabis to be used in medicine?
Today, The Royal Pharmaceutical Society is bringing together the world’s leading cannabis experts, with the aim of furthering the development and understanding of cannabis derived medicines.
Cannabis has been humankind’s friend and foe for millennia and although a lot of recent press coverage has focused on the abuses associated with Cannabis, the plant has been an essential source of medicines over the years.
But it is very clear that Cannabis causes psychotic episodes and that there are real health risks involved. With the government currently looking at re-classifying the drug from a class C to a class B drug, is there any room for Cannabis to be used in medicine?
Today, The Royal Pharmaceutical Society is bringing together the world’s leading cannabis experts, with the aim of furthering the development and understanding of cannabis derived medicines.
Stills 
Sorry. There are no stills currently available for this story.
